Clinical Trials
26 trialsProspective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain
Wake Forest University Health Sciences
EFFADOL-K
Centre Francois Baclesse
Well Being
Centre Hospitalier de Valence
CIBP
IRCCS Azienda Ospedaliero-Universitaria di Bologna
MAMETIC
National Cancer Institute, Naples
DUNE
RECORDATI GROUP
Clinical Classification of Pain in Breast Cancer Survivors
Kutahya Health Sciences University
Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients
Chongqing University Cancer Hospital
PainsCan
Universitaire Ziekenhuizen KU Leuven
Assessment of Updated Educational Materials for Instanyl®
Takeda
Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain
University of Utah
Retrospective Analysis of PET Brain Imaging in Chronic Cancer Pain
National Taiwan University Hospital
An Observation Study to Assess the Efficacy and Safety of Proportional Doses of Painkyl® in Patients With Breakthrough Cancer Pain
Mackay Memorial Hospital
IT-ESAS
University Hospital, Montpellier
StOIC-2
Royal Surrey County Hospital NHS Foundation Trust
StOIC-1
Royal Surrey County Hospital NHS Foundation Trust
QualiPain
University Hospital Schleswig-Holstein
SOOTHE
Taiwan Mundipharma Pharmaceuticals Ltd.
RER
Mario Negri Institute for Pharmacological Research
GREAT - Good Response With Appropriate Treatment
Mario Negri Institute for Pharmacological Research
Exploring New Technologies to Manage Cancer Pain in the Community
University of Aberdeen
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Janssen Korea, Ltd., Korea
The Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain Management
Janssen Korea, Ltd., Korea
Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study
Janssen Korea, Ltd., Korea
Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)
Janssen-Cilag, S.A.
Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol
Vanderbilt-Ingram Cancer Center